Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
8:22 AM, May 04, 2018  |  BC Week In Review | Company News  |  Other News

Accelerator launches Proniras to develop anticonvulsant

conduct human clinical studies to determine safety and confirm dosing. Tezampanel is an inhibitor of glutamate ionotropic receptor kainate type subunit 1 (GluK1; GRIK1; GLUR5